Capsigen
PrivateLast Round
Accelerator
Jul 12, 2023
Total Funding Raised
$15M
Company Overview
Capsigen operates in Healthcare & Life Sciences and is based in Vancouver, Washington. Its latest recorded funding round was an Accelerator round in July 2023.
Capsigen is a biotechnology company that engineers custom adeno-associated virus (AAV) capsids to deliver gene therapies for central nervous system and neuromuscular disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Capsigen Comparables
Compare Capsigen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AAVnerGene Inc. | 84% | |
| Shape Therapeutics | 83% | |
| Apertura Gene Therapy | 83% |
For institutional investors. Book with your work email.
Capsigen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 12, 2023 | ||||
| Strategic | May 10, 2021 |
For institutional investors. Book with your work email.
Capsigen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors increased 37% MoM.
- Jul 12, 2023
Received funding from Creative Destruction Lab.
For institutional investors. Book with your work email.
Capsigen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Capsigen's valuation, stock price, and market status.
Is Capsigen a public or private company?
Capsigen is a private company.
What is the current stock price of Capsigen?
Capsigen is a private company, so its shares have no public market price. Caplight tracks Capsigen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Capsigen worth (valuation)?
Valuation information for Capsigen is not publicly available.
Can I buy Capsigen stock?
Capsigen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Capsigen's last funding round?
Capsigen's most recent funding round was Accelerator on July 12, 2023.
Who are the main investors in Capsigen?
Key investors in Capsigen include Creative Destruction Lab.
Will Capsigen IPO soon?
No public IPO plans have been announced for Capsigen.
How can I track Capsigen secondary market activity?
Caplight tracks bids, offers, and trades in Capsigen's shares on secondary markets.